CT

CLINICAL TRIAL OF THE YEAR


This award recognises a European life science company that has realised a significant milestone in the clinic for a new therapy, drug, diagnostic tool, digital application or medical device.

Qualifying criteria

- Open to private or public biotech companies with a market cap of less than $10bn
- Clinical breakthrough to have been achieved in the period between 1 September 2018 and 1 September 2019

Judges will be paying particular attention to:

- Targeting of unmet medical need
- Key indicators / results / inflection points of clinical development
- Phase / speed / progress through clinical stage
- Innovative trial design / patient centric approach
- Outline of future timelines / value creation
 
 
SUBMIT YOUR NOMINATION